A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults

Published 2016 View Full Article

Authors

Keywords

Clostridium difficile, Vaccine, Toxin A, Toxin B, Neutralizing antibody, Pseudomembranous colitis

Journal

VACCINE

Volume 34, Issue 18, Pages 2082-2091

Publisher

Elsevier BV

Online

2016-03-16

DOI

10.1016/j.vaccine.2016.03.010

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now